Ninomiya T, Ishikawa N, Kozuki T, Kuyama S, et al. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naive patients with non-small cell lung cancer harboring EGFR mutations. Lung Cancer 2023;184:107349.
PMID: 37651927